Question 1

What is the catalog number for ZBTB7A discontinued?

Accepted Answer

The catalog number for ZBTB7A discontinued is 396262.

Question 2

What sizes are available for ZBTB7A discontinued?

Accepted Answer

ZBTB7A discontinued is available in the following size(s): 20 µL, 200 µL.

Question 3

How many pack sizes does ZBTB7A discontinued come in?

Accepted Answer

ZBTB7A discontinued is available in 2 different pack sizes.

Question 4

Is ZBTB7A discontinued in stock?

Accepted Answer

ZBTB7A discontinued is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

Is this product covered by a money-back guarantee?

Accepted Answer

Yes, we guarantee a full refund or store credit if this product arrives damaged beyond usability, or has a genuine performance issue under proper usage and storage, provided you report it immediately with evidence. Claims after the expiration date or due to improper storage after receipt are excluded.

Question 6

Can this product be used for diagnostic or therapeutic purposes?

Accepted Answer

No. This product, like all items we supply, is intended for research laboratory use only and must not be used for diagnostics, therapeutics, treatment, or consumption by humans or animals.

Question 7

What is the shelf life of this product?

Accepted Answer

Shelf life and expiration dates vary by product and are shown on the product listing and label. Products used beyond their expiration date are not eligible for performance-related returns or refunds, so please check the lot number and expiry before use.

ZBTB7A discontinued

Product Specifications

Clonality

Available Sizes

Frequently Asked Questions

Explore Other Products

DL-Menthyl Palmitate

MOBKL2B (MOB3B) Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI1D12]

PAPP-A / Pappalysin-1 (Marker of Atherosclerosis and Aneuploid Fetus) (PAPPA/2717), 0.2mg/mL

GCET1 (SERPINA9) (Center) Rabbit Polyclonal Antibody

AGBL3 Rabbit Polyclonal Antibody

Tmem8b Mouse Gene Knockout Kit (CRISPR)